145 related articles for article (PubMed ID: 31462110)
1. Stereotactic radiofrequency ablation of subcardiac hepatocellular carcinoma: a case-control study.
Schullian P; Johnston EW; Putzer D; Eberle G; Laimer G; Bale R
Int J Hyperthermia; 2019; 36(1):876-885. PubMed ID: 31462110
[No Abstract] [Full Text] [Related]
2. Stereotactic radiofrequency ablation as first-line treatment of recurrent HCC following hepatic resection.
Schullian P; Laimer G; Putzer D; Levy E; Braunwarth E; Stättner S; Bale R
Eur J Surg Oncol; 2020 Aug; 46(8):1503-1509. PubMed ID: 32222261
[TBL] [Abstract][Full Text] [Related]
3. Safety and efficacy of stereotactic radiofrequency ablation for very large (≥8 cm) primary and metastatic liver tumors.
Schullian P; Johnston EW; Putzer D; Eberle G; Laimer G; Bale R
Sci Rep; 2020 Jan; 10(1):1618. PubMed ID: 32005871
[TBL] [Abstract][Full Text] [Related]
4. Radiofrequency ablation for subcardiac hepatocellular carcinoma: therapeutic outcomes and risk factors for technical failure.
Cha DI; Kang TW; Song KD; Lee MW; Rhim H; Lim HK; Sinn DH; Kim K
Eur Radiol; 2019 May; 29(5):2706-2715. PubMed ID: 30506222
[TBL] [Abstract][Full Text] [Related]
5. Stereotactic Radiofrequency Ablation of Liver Tumors in Octogenarians.
Schullian P; Putzer D; Silva MA; Laimer G; Kolbitsch C; Bale R
Front Oncol; 2019; 9():929. PubMed ID: 31608232
[No Abstract] [Full Text] [Related]
6. Stereotactic radiofrequency ablation (SRFA) for recurrent colorectal liver metastases after hepatic resection.
Schullian P; Johnston EW; Putzer D; Laimer G; Waroschitz G; Braunwarth E; Amann A; Maglione M; Bale R
Eur J Surg Oncol; 2021 Apr; 47(4):866-873. PubMed ID: 33032865
[TBL] [Abstract][Full Text] [Related]
7. Feasibility, safety, and long-term efficacy of stereotactic radiofrequency ablation for tumors adjacent to the diaphragm in the hepatic dome: a case-control study.
Schullian P; Putzer D; Laimer G; Levy E; Bale R
Eur Radiol; 2020 Feb; 30(2):950-960. PubMed ID: 31489472
[TBL] [Abstract][Full Text] [Related]
8. Thermal ablation of CT 'invisible' liver tumors using MRI fusion: a case control study.
Schullian P; Johnston E; Laimer G; Putzer D; Eberle G; Westerlund P; Henninger B; Bale R
Int J Hyperthermia; 2020; 37(1):564-572. PubMed ID: 32484004
[No Abstract] [Full Text] [Related]
9. Stereotactic radiofrequency ablation of tumors at the hepatic venous confluence.
Schullian P; Johnston E; Laimer G; Scharll Y; Putzer D; Eberle G; Kolbitsch C; Amann A; Stättner S; Bale R
HPB (Oxford); 2022 Jul; 24(7):1044-1054. PubMed ID: 34887174
[TBL] [Abstract][Full Text] [Related]
10. Stereotactic radiofrequency ablation of primary liver tumors in the caudate lobe.
Schullian P; Laimer G; Putzer D; Effenberger M; Bale R
HPB (Oxford); 2020 Mar; 22(3):470-478. PubMed ID: 31591012
[TBL] [Abstract][Full Text] [Related]
11. Stereotactic radiofrequency ablation (SRFA) of liver lesions: technique effectiveness, safety, and interoperator performance.
Widmann G; Schullian P; Haidu M; Bale R
Cardiovasc Intervent Radiol; 2012 Jun; 35(3):570-80. PubMed ID: 21671150
[TBL] [Abstract][Full Text] [Related]
12. Stereotactic Radiofrequency Ablation of Breast Cancer Liver Metastases: Short- and Long-Term Results with Predicting Factors for Survival.
Schullian P; Johnston E; Laimer G; Putzer D; Eberle G; Scharll Y; Ianetti-Hackl C; Bale R
Cardiovasc Intervent Radiol; 2021 Aug; 44(8):1184-1193. PubMed ID: 33825059
[TBL] [Abstract][Full Text] [Related]
13. Radiofrequency ablation vs. surgery for perivascular hepatocellular carcinoma: Propensity score analyses of long-term outcomes.
Lee S; Kang TW; Cha DI; Song KD; Lee MW; Rhim H; Lim HK; Sinn DH; Kim JM; Kim K
J Hepatol; 2018 Jul; 69(1):70-78. PubMed ID: 29524532
[TBL] [Abstract][Full Text] [Related]
14. Percutaneous stereotactic radiofrequency ablation of colorectal liver metastases.
Bale R; Widmann G; Schullian P; Haidu M; Pall G; Klaus A; Weiss H; Biebl M; Margreiter R
Eur Radiol; 2012 Apr; 22(4):930-7. PubMed ID: 22071776
[TBL] [Abstract][Full Text] [Related]
15. Stereotactic Radiofrequency Ablation for Metastatic Melanoma to the Liver.
Bale R; Schullian P; Schmuth M; Widmann G; Jaschke W; Weinlich G
Cardiovasc Intervent Radiol; 2016 Aug; 39(8):1128-35. PubMed ID: 27055850
[TBL] [Abstract][Full Text] [Related]
16. Technical efficacy and local recurrence after stereotactic radiofrequency ablation of 2653 liver tumors: a 15-year single-center experience with evaluation of prognostic factors.
Schullian P; Laimer G; Johnston E; Putzer D; Eberle G; Scharll Y; Widmann G; Kolbitsch C; Bale R
Int J Hyperthermia; 2022; 39(1):421-430. PubMed ID: 35227136
[TBL] [Abstract][Full Text] [Related]
17. [The therapeutic outcomes of ultrasound-guided percutaneous radiofrequency therapy for subcardiac liver malignant tumor].
Zhou YZ; Zhu RL; Ouyang JZ; Yu KL; Wang ZZ; Li QJ; Zhou JX
Zhonghua Wai Ke Za Zhi; 2020 Oct; 58(10):770-775. PubMed ID: 32993264
[No Abstract] [Full Text] [Related]
18. Frequency and risk factors for major complications after stereotactic radiofrequency ablation of liver tumors in 1235 ablation sessions: a 15-year experience.
Schullian P; Johnston E; Laimer G; Putzer D; Eberle G; Amann A; Effenberger M; Maglione M; Freund MC; Loizides A; Bale R
Eur Radiol; 2021 May; 31(5):3042-3052. PubMed ID: 33125554
[TBL] [Abstract][Full Text] [Related]
19. Simultaneous Stereotactic Radiofrequency Ablation of Multiple (≥ 4) Liver Tumors: Feasibility, Safety, and Efficacy.
Schullian P; Putzer D; Eberle G; Laimer G; Bale R
J Vasc Interv Radiol; 2020 Jun; 31(6):943-952. PubMed ID: 32414570
[TBL] [Abstract][Full Text] [Related]
20. Reliability of Stereotactic Radiofrequency Ablation (SRFA) for Malignant Liver Tumors: Novice versus Experienced Operators.
Schullian P; Laimer G; Johnston E; Putzer D; Eberle G; Widmann G; Scharll Y; Bale R
Biology (Basel); 2023 Jan; 12(2):. PubMed ID: 36829454
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
